Get the Stockscreener App
0.4201
1.82%
0.0075
After Hours:
.41
-0.0101
-2.40%
Klotho Neurosciences Inc stock is traded at $0.4201, with a volume of 6.59M.
It is up +1.82% in the last 24 hours and up +90.35% over the past month.
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.
See More
Previous Close:
$0.4126
Open:
$0.4101
24h Volume:
6.59M
Relative Volume:
2.42
Market Cap:
$30.47M
Revenue:
-
Net Income/Loss:
$-11.35M
P/E Ratio:
-0.9225
EPS:
-0.4554
Net Cash Flow:
$-5.51M
1W Performance:
-12.11%
1M Performance:
+90.35%
6M Performance:
-13.40%
1Y Performance:
+37.11%
1-Day Range:
$0.37
$0.4299
1-Week Range:
$0.37
$0.7398
52-Week Range:
$0.1135
$3.9099
Klotho Neurosciences Inc Stock (KLTO) Company Profile
Name
Klotho Neurosciences Inc
Sector
Industry
Phone
(833) 931-6330
Address
13576 WALNUT STREET, SUITE A, OMAHA
Compare KLTO vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KLTO
Klotho Neurosciences Inc
|
0.4201 | 29.93M | 0 | -11.35M | -5.51M | -0.4554 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.11 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Klotho Neurosciences Inc Stock (KLTO) Latest News
Klotho Neurosciences Expands Into Mining With Greenland Mines Deal - Yahoo Finance
Klotho Neurosciences acquires Greenland palladium-gold project - Investing.com
Klotho Neurosciences Completes Reverse Merger Greenland Mines Acquisition - TipRanks
Klotho Neurosciences (Nasdaq: KLTO) to rebrand after Greenland Mines deal - Stock Titan
Klotho Neurosciences Acquires Control of Palladium, Gold Mine in Greenland - marketscreener.com
Klotho Neurosciences Acquires Greenland Mines Corp., Securing Control Of A $68 Billion Palladium, Gold, Platinum, And Critical Mineral Deposit In The World's Most Strategically Vital Emerging Trade Corridor - TradingView
KLOTHO NEUROSCIENCES ACQUIRES GREENLAND MINES CORP., SECURING CONTROL OF A $68 BILLION PALLADIUM, GOLD, PLATINUM, AND CRITICAL MINERAL DEPOSIT IN THE WORLD'S MOST STRATEGICALLY VITAL EMERGING TRADE C - PR Newswire
Klotho Neurosciences Raises $7.75 Million in Private Placement - TipRanks
Klotho Neurosciences completes $7.75 million private placement of shares and warrants - Investing.com South Africa
Klotho Neurosciences (NASDAQ: KLTO) closes $7,750,000 private placement - Stock Titan
MACD Signal: Is Klotho Neurosciences Inc Equity Warrant affected by consumer sentimentJuly 2025 Trends & Verified Swing Trading Watchlists - baoquankhu1.vn
Klotho Neurosciences, Inc. announced that it has received $7.75 million in funding - marketscreener.com
What is the earnings history of Klotho Neurosciences Inc. Equity Warrant2025 Institutional Moves & Precise Swing Trade Alerts - mfd.ru
CEO Change: Is Klotho Neurosciences Inc forming a breakout pattern2025 Momentum Check & Target Return Focused Picks - baoquankhu1.vn
KLTO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
KLTO PE Ratio & Valuation, Is KLTO Overvalued - Intellectia AI
Klotho Neurosciences (NASDAQ:KLTO) Upgraded by Wall Street Zen to “Hold” Rating - Defense World
Should I Buy KLTO? KLTO 2026 AnalysisIntellectia AI™ - Intellectia AI
KLTOW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Klotho Neurosciences (NASDAQ:KLTO) Initiates Development of the "Klotho Clock," a Diagnostic Biological Aging and Longevity Clock that Unlocks Health Testing Through Epigenetics and Artificial Intelligence (AI) - Finviz
Klotho Neurosciences, Inc. (KLTO) has officially signed a securities purchase agreement. According to the latest documents submitted to the U.S. Securities and Exchange Commission (SEC), the company plans to issue a total of 34.6 million shares of common - Bitget
Klotho Neurosciences Raises $7.75M at $0.2243/Share, Issues Five-Year Warrants - TradingView
Klotho Neurosciences (KLTO) sets 34.6M-share stock and warrant sale - Stock Titan
Klotho Neurosciences, Inc. (KLTO) has officially signed a securities purchase agreement. According to the latest filings submitted to the U.S. Securities and Exchange Commission (SEC), the company plans to issue a total of 34.6 million shares of common stoc - Bitget
Entry Recap: What drives Klotho Neurosciences Incs stock priceJuly 2025 Fed Impact & Verified Entry Point Signals - baoquankhu1.vn
What are Klotho Neurosciences Inc. Equity Warrant’s growth levers2025 Market Trends & Weekly Top Gainers Alerts - mfd.ru
Is Klotho Neurosciences Inc. Equity Warrant forming a double bottomMarket Risk Report & High Conviction Investment Ideas - mfd.ru
Does Klotho Neurosciences Inc. have declining or rising EPSExit Point & Reliable Volume Spike Alerts - mfd.ru
How Klotho Neurosciences Inc. stock compares to industry benchmarks2025 Risk Factors & Fast Entry Momentum Trade Alerts - mfd.ru
Klotho Neurosciences Receives Patent Claims in Australia for Composition and Use of Human Secreted Klotho Protein ("s-KL") Isoform of the Human Klotho Gene Sequence - Sharecast.com
Klotho Neurosciences, Inc. announced that it expects to receive $7.75 million in funding - marketscreener.com
Klotho Neurosciences Receives Patent Claims in Australia for Com - GuruFocus
Klotho Neurosciences Shareholders Approve Reverse Stock Split - TipRanks
Will Klotho Neurosciences Inc. stock maintain dividend yieldWeekly Trend Report & AI Based Buy/Sell Signal Reports - mfd.ru
Pullback Watch: Will Klotho Neurosciences Inc Equity Warrant stock recover after earnings2025 Volume Leaders & Free Safe Capital Growth Stock Tips - baoquankhu1.vn
Is Klotho Neurosciences Inc. stock a top pick in earnings season2025 Fundamental Recap & Reliable Breakout Stock Forecasts - mfd.ru
Is Klotho Neurosciences Inc. Equity Warrant stock ready for breakout2025 Market Sentiment & Smart Allocation Stock Tips - mfd.ru
Can Klotho Neurosciences Inc. Equity Warrant stock withstand economic slowdown2025 Winners & Losers & Risk Adjusted Swing Trade Ideas - mfd.ru
Can Klotho Neurosciences Inc. Equity Warrant grow without external fundingJuly 2025 Recap & Weekly Momentum Picks - mfd.ru
Institution Moves: Can DNUT grow without external fundingWeekly Market Summary & Daily Technical Stock Forecast Reports - baoquankhu1.vn
Rally Mode: Is Klotho Neurosciences Inc gaining market shareTrend Reversal & Safe Capital Preservation Plans - baoquankhu1.vn
Hedge Fund Bets: Is Klotho Neurosciences Inc Equity Warrant affected by consumer sentimentTrade Volume Report & Free Community Consensus Stock Picks - baoquankhu1.vn
Momentum Shift: What is the PEG ratio of Klotho Neurosciences Inc Equity WarrantJuly 2025 Volume & Scalable Portfolio Growth Methods - baoquankhu1.vn
What’s the beta of Klotho Neurosciences Inc. stock2025 Risk Factors & Real-Time Volume Surge Alerts - mfd.ru
Whats the beta of Klotho Neurosciences Inc stockWeekly Market Report & High Return Trade Opportunity Guides - baoquankhu1.vn
Retail Trends: Is XOMA stock showing strong momentumMarket Trend Summary & AI Enhanced Execution Alerts - baoquankhu1.vn
KLTOW SEC FilingsKlotho Neurosciences, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
CEO Change: Is Klotho Neurosciences Inc Equity Warrant affected by consumer sentimentJuly 2025 Analyst Calls & Low Drawdown Trading Techniques - baoquankhu1.vn
Is Klotho Neurosciences Inc. stock attractive for passive investorsQuarterly Market Summary & High Win Rate Trade Alerts - bollywoodhelpline.com
CEO Change: Is Klotho Neurosciences Inc gaining market shareJuly 2025 Rallies & Weekly Sector Rotation Insights - baoquankhu1.vn
Bear Alert: Is Steven Madden Ltd attractive for institutional investors2025 Market Trends & Community Consensus Trade Signals - baoquankhu1.vn
Klotho Neurosciences Inc Stock (KLTO) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.69%
0.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):